Max Robotics — Global Service Robot Directory + US Certification

About

Takashi Matsuoka is a urologic surgeon and researcher whose work focuses on optimizing outcomes in robot-assisted surgery for renal cell carcinoma and prostate cancer. His primary research areas include perioperative anticoagulation management, surgical quality metrics, and intraoperative tumor visualization. Matsuoka’s most cited study, “Effect of Continued Perioperative Anticoagulant Therapy on Bleeding Outcomes Following Robot-assisted Radical Prostatectomy” (2020, 11 citations), provides critical evidence on safely managing anticoagulated patients during high-risk urologic procedures. He has also advanced the concept of “trifecta” outcomes—simultaneously achieving negative margins, minimal complications, and preserved renal function—in robot-assisted partial nephrectomy for T1b tumors (2023). Most notably, his pioneering 2025 work on 5-aminolevulinic acid-induced fluorescence demonstrates that protoporphyrin IX accumulation differs between tumor and normal renal tissues, offering a real-time intraoperative guide for more precise resection margins. By bridging surgical technique with fluorescence-guided imaging, Matsuoka is helping to define the next generation of nephron-sparing surgery. His research is particularly valuable for surgeons seeking to reduce complications while maximizing oncologic and functional outcomes.